News

- The increasing demand for non-invasive testing methodologies and rising chronic disease incidence are driving the demand for the market. - Market Size – USD 3.80 billion in 2019, Market Growth ...
Researchers from Geneseeq and a network of Chinese academic hospitals have validated a blood test that can detect a broad range of cancers with high accuracy using cell-free DNA. A multi-cancer ...
The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis. BJOG 2017;124:32-46. Crossref. PubMed.
In European countries, cell-free DNA has already been used as a standard of care to determine fetal antigen status and guide pregnancy management. Data was derived from Rego S, et al. Obstet ...
Among liquid biopsy–based methodologies, cell-free DNA (cfDNA)–related early diagnosis technology is relatively mature, and relevant commercial detection kits have been approved. 8 The main ...
Innovations in cell-free gene synthesis decrease turnaround times for obtaining full-length, complex, NGS-verified DNA from weeks or months to as few as 6-8 business days. Cell-free DNA speeds ...
Two medical societies have responded to a recent article on cell-free fetal DNA testing in low-risk women, with mixed recommendations for clinicians. News & Perspective Drugs & Diseases ...
The sensitivity of this blood-based test for colorectal cancer was 83.1%, whereas reported sensitivity of other noninvasive screening tests ranges from 67.3% (95% CI, 57.1 to 76.5) with FIT 15 and ...
Get Instant Summarized Text (Gist) A blood test analyzing cell-free DNA with whole-genome sequencing and machine learning demonstrated 87.4% sensitivity and 97.8% specificity for multi-cancer ...